This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Andrade-Neto, V. F.
Right arrow Articles by Krettli, A. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Andrade-Neto, V. F.
Right arrow Articles by Krettli, A. U.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2007, p. 2346-2350, Vol. 51, No. 7
0066-4804/07/$08.00+0     doi:10.1128/AAC.01344-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Antiplasmodial Activity of Aryltetralone Lignans from Holostylis reniformis{triangledown}

Valter F. de Andrade-Neto,1,2,{dagger} Tito da Silva,3 Lucia M. Xavier Lopes,3* Virgílio E. do Rosário,4 Fernando de Pilla Varotti,1 and Antoniana U. Krettli1

Laboratório de Malaria, Centro de Pesquisas René Rachou/FIOCRUZ, 30190-002, Belo Horizonte, MG, Brazil,1 Departamento de Parasitologia, Universidade Federal de Minas Gerais, UFMG, Av. Augusto de Lima, 1715, 30190-002, Belo Horizonte, MG, Brazil,2 Instituto de Química, Universidade Estadual Paulista, UNESP, C. P. 355, 14801-970, Araraquara, SP, Brazil,3 Instituto de Higiene e Medicina Tropical, Centro de Malaria e Doenças Tropicais, Universidade Nova de Lisboa, UNL, 1349-008, Lisboa, Portugal4

Received 26 October 2006/ Returned for modification 12 November 2006/ Accepted 3 April 2007

Extracts from Holostylis reniformis were tested in vivo against Plasmodium berghei and in vitro against a chloroquine-resistant strain of Plasmodium falciparum. The hexane extract of the roots was the most active, causing 67% reduction of parasitemia in vivo. From this extract, six lignans, including a new (7'R,8S,8'S)-3',4'-methylenedioxy-4,5-dimethoxy-2,7'-cyclolignan-7-one, were isolated and tested in vitro against P. falciparum. The three most active lignans showed 50% inhibitor concentrations of ≤0.32 µM. An evaluation of minimum lethal dose (30%) values showed low toxicity for these lignans in a hepatic cell line (Hep G2A16). Therefore, these compounds are potential candidates for the development of antimalarial drugs.


* Corresponding author. Mailing address: Instituto de Química, Universidade Estadual Paulista, UNESP, R. Francisco Degni s/n, C. P. 355, 14801-970, Araraquara, SP, Brazil. Phone: (55) 16-3301-6663. Fax: (55) 16-3301-6692. E-mail: lopesxl{at}iq.unesp.br

{triangledown} Published ahead of print on 16 April 2007.

{dagger} Present address: Departamento de Microbiologia e Parasitologia, Universidade Federal do Rio Grande do Norte, UFRN, 59072-970, Natal, RN, Brazil.


Antimicrobial Agents and Chemotherapy, July 2007, p. 2346-2350, Vol. 51, No. 7
0066-4804/07/$08.00+0     doi:10.1128/AAC.01344-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.